35.14
Precedente Chiudi:
$36.10
Aprire:
$36.17
Volume 24 ore:
262.98K
Relative Volume:
0.19
Capitalizzazione di mercato:
$1.97B
Reddito:
$249.12M
Utile/perdita netta:
$-90.19M
Rapporto P/E:
-20.67
EPS:
-1.7
Flusso di cassa netto:
$-88.21M
1 W Prestazione:
+0.71%
1M Prestazione:
+18.72%
6M Prestazione:
-41.64%
1 anno Prestazione:
-60.58%
Procept Biorobotics Corp Stock (PRCT) Company Profile
Nome
Procept Biorobotics Corp
Settore
Industria
Telefono
(650) 232-9832
Indirizzo
150 BAYTECH DRIVE, SAN JOSE
Confronta PRCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PRCT
Procept Biorobotics Corp
|
35.17 | 2.02B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
126.92 | 223.39B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
91.25 | 136.67B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.05 | 135.88B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.75 | 126.37B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.53 | 48.39B | 5.88B | 1.34B | 799.60M | 2.3489 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Iniziato | UBS | Buy |
| 2025-12-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-09-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Iniziato | Stephens | Overweight |
| 2025-07-07 | Iniziato | Oppenheimer | Perform |
| 2024-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Iniziato | Jefferies | Hold |
| 2023-08-11 | Iniziato | Piper Sandler | Overweight |
| 2023-05-31 | Iniziato | William Blair | Outperform |
| 2022-10-31 | Iniziato | BTIG Research | Neutral |
| 2022-10-25 | Iniziato | Truist | Buy |
| 2022-09-02 | Iniziato | Wells Fargo | Overweight |
| 2022-07-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Goldman | Neutral |
| 2021-10-11 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
3 Underrated Robotics Stocks Poised for Huge Gains - Yahoo Finance
Squarepoint Ops LLC Decreases Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Downgraded by Wall Street Zen to Sell - MarketBeat
Bellevue Group AG Acquires 74,355 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth - Investing.com Australia
PRCT FinancialsIncome Statement - Quiver Quantitative
Frontier Capital Management Co. LLC Acquires 203,602 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth By Investing.com - Investing.com South Africa
Axa S.A. Purchases 63,519 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Next Century Growth Investors LLC Buys 62,112 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Federated Hermes Inc. Acquires 25,863 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Does PROCEPT BioRobotics (PRCT) Slower Aquablation Uptake Recast Its Long-Term Market Penetration Story? - Yahoo Finance
PROCEPT BioRobotics’ (PRCT) “Neutral” Rating Reaffirmed at Bank of America - Defense World
PROCEPT BioRobotics Faces Slower Growth As BofA Lowers Rating - Finimize
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap DownHere's Why - MarketBeat
PROCEPT BioRobotics has Large Market Opportunity, but Utilization Growth has Slowed, BofA Says - marketscreener.com
Procept BioRobotics stock downgraded by BofA on slowing growth - Investing.com Australia
PROCEPT BioRobotics Corporation $PRCT Shares Acquired by Thematics Asset Management - MarketBeat
B of A Securities downgrades PROCEPT BioRobotics (PRCT) - MSN
Wall Street Zen Upgrades PROCEPT BioRobotics (NASDAQ:PRCT) to Hold - Defense World
Wall Street analysts’ outlook for Procept BioRobotics Corp (PRCT) - setenews.com
Is PROCEPT BioRobotics Corporation stock a buy before product launchesWeekly Stock Report & Short-Term High Return Ideas - Newser
Granite Investment Partners LLC Makes New Investment in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Mackenzie Financial Corp Buys New Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (PRCT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Loomis Sayles & Co. L P Has $67.47 Million Stock Holdings in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Are Smart Investors Making the Right Decision? Procept BioRobotics Corp (PRCT) - setenews.com
Morgan Stanley Initiates Coverage of PROCEPT BioRobotics (PRCT) with Overweight Recommendation - MSN
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
PROCEPT BioRobotics Corporation (PRCT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
First Week of July 2026 Options Trading For PROCEPT BioRobotics (PRCT) - Nasdaq
Procept BioRobotics Corp (PRCT) looking to reclaim success with recent performance - Setenews
PROCEPT BioRobotics To Spotlight Aquablation Growth At Piper Sandler Event Next Month - Nasdaq
PROCEPT BioRobotics Corporation $PRCT Holdings Raised by Artisan Partners Limited Partnership - Defense World
PROCEPT BioRobotics (NASDAQ: PRCT) to present at 37th Annual Piper Sandler Conference - Stock Titan
Is PROCEPT BioRobotics Corporation stock gaining market shareJuly 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Is PROCEPT BioRobotics Corporation stock positioned well for digital economy2025 Key Lessons & Daily Volume Surge Trade Alerts - newser.com
Will PROCEPT BioRobotics Corporation stock deliver long term returnsBear Alert & Weekly High Potential Stock Alerts - newser.com
How PROCEPT BioRobotics Corporation stock valuations compare to rivalsJuly 2025 Closing Moves & Precise Buy Zone Tips - newser.com
Mitsubishi UFJ Trust & Banking Corp Makes New Investment in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Will PROCEPT BioRobotics Corporation outperform the marketMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT) - Insider Monkey
Comparing PROCEPT BioRobotics Corporation in custom built stock radars2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
PROCEPT BioRobotics (PRCT) Price Target Decreased by 16.88% to 55.27 - MSN
Candriam S.C.A. Grows Stock Holdings in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Reaches New 12-Month LowHere's Why - MarketBeat
Los Angeles Capital Management LLC Sells 15,863 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Calamos Advisors LLC Invests $1.56 Million in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
How institutional ownership impacts PROCEPT BioRobotics Corporation stockWeekly Gains Summary & Real-Time Volume Spike Alerts - newser.com
Procept Biorobotics Corp Azioni (PRCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Procept Biorobotics Corp Azioni (PRCT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MOLL FREDERIC H | Director |
Aug 13 '25 |
Buy |
39.26 |
20,000 |
785,138 |
863,159 |
| Nouri Alaleh | EVP, CLO, CORP. SEC. |
Aug 14 '25 |
Option Exercise |
4.52 |
11,000 |
49,720 |
72,473 |
| Desai Antal Rohit | Director |
Jun 10 '25 |
Sale |
63.91 |
25,000 |
1,597,711 |
64,363 |
| Desai Antal Rohit | Director |
Jun 11 '25 |
Sale |
63.38 |
25,000 |
1,584,525 |
39,363 |
| Desai Antal Rohit | Director |
Jun 12 '25 |
Sale |
61.49 |
25,000 |
1,537,256 |
14,363 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):